From Heuristic to Mathematical Modeling of Drugs Dissolution Profiles: Application of Artificial Neural Networks and Genetic Programming
暂无分享,去创建一个
Sebastian Polak | Renata Jachowicz | Peter Kleinebudde | Aleksander Mendyk | Jakub Szlek | Sinan Güres | Barbara Wisniowska | P. Kleinebudde | R. Jachowicz | S. Polak | J. Szlęk | A. Mendyk | B. Wiśniowska | S. Güres
[1] Fumiyoshi Yamashita,et al. Computer-based evolutionary search for a nonlinear conversion function for establishing in vitro-in vivo correlation (IVIVC) of oral drug formulations. , 2012, Drug metabolism and pharmacokinetics.
[2] H Schmidli,et al. Advantages of Artificial Neural Networks (ANNs) as alternative modelling technique for data sets showing non-linear relationships using data from a galenical study on a solid dosage form. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[3] N. Peppas,et al. EFFECT OF THE MORPHOLOGY OF HYDROPHILIC POLYMERIC MATRICES ON THE DIFFUSION AND RELEASE OF WATER SOLUBLE DRUGS , 1981 .
[4] Jacek M. Zurada,et al. Neural Network Predicted Peak and Trough Gentamicin Concentrations , 1995, Pharmaceutical Research.
[5] P. Kleinebudde,et al. Drug release from extruded solid lipid matrices: theoretical predictions and independent experiments. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[6] Jacek M. Zurada,et al. Perturbation method for deleting redundant inputs of perceptron networks , 1997, Neurocomputing.
[7] Buket Aksu,et al. A quality by design approach using artificial intelligence techniques to control the critical quality attributes of ramipril tablets manufactured by wet granulation , 2013, Pharmaceutical development and technology.
[8] Antonio Gasparrini,et al. Distributed Lag Linear and Non-Linear Models in R: The Package dlnm. , 2011, Journal of statistical software.
[9] Stanislav Primožič,et al. Prediction of Pharmacokinetic Parameters and the Assessment of Their Variability in Bioequivalence Studies by Artificial Neural Networks , 1999, Pharmaceutical Research.
[10] Kenji Nishizawa,et al. Artificial neural network modeling to predict the plasma concentration of aminoglycosides in burn patients. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[11] N. Peppas,et al. In honor of Takeru Higuchi. , 2011, International journal of pharmaceutics.
[12] Michael Melkonian,et al. Genetic Programming as a tool for identification of analyte-specificity from complex response patterns using a non-specific whole-cell biosensor. , 2012, Biosensors & bioelectronics.
[13] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[14] Igor Skrjanc,et al. Tableting process optimisation with the application of fuzzy models. , 2010, International journal of pharmaceutics.
[15] J. Siepmann,et al. Hydrophilic Matrices for Controlled Drug Delivery: An Improved Mathematical Model to Predict the Resulting Drug Release Kinetics (the “sequential Layer” Model) , 2004, Pharmaceutical Research.
[16] M. Poynton,et al. Machine Learning Methods Applied to Pharmacokinetic Modelling of Remifentanil in Healthy Volunteers: A Multi-Method Comparison , 2009, The Journal of international medical research.
[17] A. Sakr,et al. Artificial neural network analysis of a direct compression tabletting study , 1995 .
[18] Juergen Siepmann,et al. Modeling of diffusion controlled drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[19] Renata Jachowicz,et al. Unified methodology of neural analysis in decision support systems built for pharmaceutical technology , 2007, Expert Syst. Appl..
[20] John C. Nash,et al. Unifying Optimization Algorithms to Aid Software System Users: optimx for R , 2011 .
[21] J. Parojčić,et al. In vitro--in silico--in vivo drug absorption model development based on mechanistic gastrointestinal simulation and artificial neural networks: nifedipine osmotic release tablets case study. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[22] Renata Jachowicz,et al. pplication of artificial neural networks ( ANNs ) and genetic programming ( GP ) or prediction of drug release from solid lipid matrices , 2012 .
[23] Marcel de Matas,et al. Evaluation of an in vitro in vivo correlation for nebulizer delivery using artificial neural networks. , 2007, Journal of pharmaceutical sciences.
[24] Jakub Szlęk,et al. Analysis of pellet properties with use of artificial neural networks. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[25] Mohammad Wahab Khan,et al. A survey of application: genomics and genetic programming, a new frontier. , 2012, Genomics.
[26] P. Kulinowski,et al. KinetDS: An Open Source Software for Dissolution Test Data Analysis , 2012 .
[27] Renata Jachowicz,et al. Neural network as a decision support system in the development of pharmaceutical formulation - focus on solid dispersions , 2005, Expert Syst. Appl..
[28] D J Roe,et al. Application of neural networks to population pharmacokinetic data analysis. , 1997, Journal of pharmaceutical sciences.
[29] K. Kachrimanis,et al. Solid dispersions in the development of a nimodipine floating tablet formulation and optimization by artificial neural networks and genetic programming. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[30] Svetlana Ibrić,et al. An investigation into the usefulness of generalized regression neural network analysis in the development of level A in vitro-in vivo correlation. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[31] Jacek M. Zurada,et al. Introduction to artificial neural systems , 1992 .
[32] T. Higuchi,et al. Rate of release of medicaments from ointment bases containing drugs in suspension. , 1961, Journal of pharmaceutical sciences.
[33] Igor Skrjanc,et al. Minimisation of the capping tendency by tableting process optimisation with the application of artificial neural networks and fuzzy models. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[34] Hao Ying,et al. Essentials of fuzzy modeling and control , 1995 .